Mesenchymal Stromal Cells as Treatment of Chronic Graft-versus-host Disease
Stopped New requirements for study approval with the Swedish Medical Products Agency
Conditions
- Graft-Versus-Host Disease
Interventions
- BIOLOGICAL: Mesenchymal stromal cells
Sponsor
Karolinska Institutet
Collaborators